Insights

Accelerating Therapies With Curia From Conception to Manufacturing

icons/content-types/article article

Drug Product Manufacturing

Partnering with a CDMO can help streamline drug development, and certain preparations can help ensure a successful collaboration. Scott Alderucci, Curia’s Director of Process Development, explores the advantages of partnering with a CDMO to navigate the journey from molecule conception to clinical trials, including the expertise, experience, and preparedness that a CDMO brings to the table.

  • The benefits of partnering with a CDMO for navigating the journey from molecule conception to clinical trials.
  • Insights into key considerations like the optimal stage to engage with a CDMO and necessary preparations for successful collaboration.
  • Curia and the expertise it brings to the table in biologics and small molecules.

Download the Article

In addition to the article, listen to this podcast with greater insight from Curia’s Director, Process Development Science, Scott Alderucci, who leads the process development group at Curia, a global CDMO offering CDMO expertise for biologics and small molecules.



Ready to move from idea to impact?

Whether you have a question for our team or an opportunity you’re eager to pursue, one of our experts can help you get started.

Contact Us
More from Curia

040E93C7-D189-4233-A102-58C0580BE529 publications patents

Development of a rapid image-based high-content imaging screening assay to evaluate therapeutic antibodies against the monkeypox virus

This rapid high-content method utilizing state-of-theart technologies enabled the evaluation of hundreds of mAbs quickly to identify several potent anti-MPXV neutralizing mAbs for further development.

040E93C7-D189-4233-A102-58C0580BE529 publications patents

Mouse Antibodies with Activity Against the SARS-CoV-2 D614G and B.1.351 Variants

We describe mouse antibodies B13 and O24 that demonstrate neutralizing potency against SARSCoV-2 Wuhan (D614G) and B.1.351 variants. Such murine antibodies may have advantages in protecting against severe symptoms when individuals are exposed to new...